| Product Code: ETC8271629 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Age-Related Macular Degeneration Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Age-Related Macular Degeneration Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Age-Related Macular Degeneration Market - Industry Life Cycle |
3.4 Mexico Age-Related Macular Degeneration Market - Porter's Five Forces |
3.5 Mexico Age-Related Macular Degeneration Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Mexico Age-Related Macular Degeneration Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Mexico Age-Related Macular Degeneration Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Age-Related Macular Degeneration Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration in Mexico |
4.2.2 Growing awareness about eye health and early detection of eye diseases |
4.2.3 Technological advancements in diagnostic tools and treatment options for age-related macular degeneration |
4.3 Market Restraints |
4.3.1 High cost associated with advanced treatments for age-related macular degeneration |
4.3.2 Limited access to specialized healthcare services in certain regions of Mexico |
4.3.3 Lack of reimbursement policies for expensive treatments |
5 Mexico Age-Related Macular Degeneration Market Trends |
6 Mexico Age-Related Macular Degeneration Market, By Types |
6.1 Mexico Age-Related Macular Degeneration Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Mexico Age-Related Macular Degeneration Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Mexico Age-Related Macular Degeneration Market Revenues & Volume, By Eylea, 2021- 2031F |
6.1.4 Mexico Age-Related Macular Degeneration Market Revenues & Volume, By Lucentis, 2021- 2031F |
6.1.5 Mexico Age-Related Macular Degeneration Market Revenues & Volume, By Beovu, 2021- 2031F |
6.1.6 Mexico Age-Related Macular Degeneration Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mexico Age-Related Macular Degeneration Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Mexico Age-Related Macular Degeneration Market Revenues & Volume, By Dry AMD, 2021- 2031F |
6.2.3 Mexico Age-Related Macular Degeneration Market Revenues & Volume, By Wet AMD, 2021- 2031F |
6.3 Mexico Age-Related Macular Degeneration Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Mexico Age-Related Macular Degeneration Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Mexico Age-Related Macular Degeneration Market Revenues & Volume, By Specialty Pharmacy, 2021- 2031F |
6.3.4 Mexico Age-Related Macular Degeneration Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Mexico Age-Related Macular Degeneration Market Import-Export Trade Statistics |
7.1 Mexico Age-Related Macular Degeneration Market Export to Major Countries |
7.2 Mexico Age-Related Macular Degeneration Market Imports from Major Countries |
8 Mexico Age-Related Macular Degeneration Market Key Performance Indicators |
8.1 Number of screenings conducted for early detection of age-related macular degeneration |
8.2 Adoption rate of new diagnostic tools and treatment options in the market |
8.3 Patient satisfaction levels with the quality of care and treatment outcomes |
8.4 Percentage of healthcare professionals trained in managing age-related macular degeneration |
8.5 Rate of disease progression in patients receiving different treatment modalities |
9 Mexico Age-Related Macular Degeneration Market - Opportunity Assessment |
9.1 Mexico Age-Related Macular Degeneration Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Mexico Age-Related Macular Degeneration Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Mexico Age-Related Macular Degeneration Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Age-Related Macular Degeneration Market - Competitive Landscape |
10.1 Mexico Age-Related Macular Degeneration Market Revenue Share, By Companies, 2024 |
10.2 Mexico Age-Related Macular Degeneration Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here